✦ LIBER ✦

Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts

✍ Scribed by John A. Hamilton; Daisy Cheung; Enrico L. Filonzi; Diana S. Piccoli; Johann Wojta; Marisa Gallichio; Katherine McGrath; Karena Last

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 895 KB
Volume: 35
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780351217

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen activator inhibitor 1 in hum

Plasminogen activator inhibitor 1 in human carcinoma tissues

✍ Nobuya Tanaka; Hideharu Fukao; Shigeru Ueshima; Kiyotaka Okada; Masayuki Yasutom 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 577 KB

## Abstract The content of PAI‐1 was measured in carcinoma tissues from the stomach and colorectum divided macroscopically into 3 portions: the central part of the carcinoma, the marginal part of the carcinoma containing some normal mucosa, and the normal mucosa. Among these tissues, the highest le

Expression of urokinase-type plasminogen

Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease

✍ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.

Expression of plasminogen activators and

Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma

✍ Carsten Häckel; Bogdan Czerniak; Alberto G. Ayala; Kathrin Radig; Albert Roessne 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

## Background: The plasminogen activator system plays an important role in different malignant tumors. these enzymes participate in the destruction of intercellular matrices and basement membranes and/or can modulate the growth potency of tumor cells and may even promote metastases. in this study,

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA

✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an

Topological localization of plasminogen

Topological localization of plasminogen activator inhibitor type 2

✍ Michael A. Liew; Virginia McPhun; Mark S. Baker 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

Background: Plasminogen activator inhibitor type 2 (PAI-2) is a member of the serine protease inhibitor (SER-PIN) superfamily and forms stable complexes with urokinase type plasminogen activator (uPA). uPA can be found on the cell surface attached to its specific receptor (uPAR), allowing for contro

Prostatic human kallikrein 2 inactivates

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1

✍ Stephen D. Mikolajczyk; Lisa S. Millar; Abhay Kumar; Mohammad S. Saedi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 77 KB

Human kallikrein 2 (hK2) is a serine protease expressed predominantly in the prostate which has 80% homology to prostate-specific antigen (PSA). hK2 is an active trypsin-like protease which has been shown by immuno-histochemical staining to be more highly expressed in prostate carcinoma than in beni